Summary Three human cell lines derived from oro-pharyngeal squamous cell carcinomas of the head were investigated for bone-resorbing activity in vitro. Culture media from all three spontaneously produced a non-dialysable osteolytic factor with activity in three in vitro assays for interleukin 1 (ILl), viz. the lymphocyte activating factor (LAF) assay, stimulation of collagenase synthesis by articular chondrocytes, and stimulation of prostaglandin E2 synthesis by fibroblasts. Addition of anti-human ILl antibody to the culture media abolished all the bone-resorbing activity. Fractionation of the cell culture media by high performance liquid chromatography (HPLC) showed a single peak of activity in the chondrocyte assay with an apparent mol.wt of 15-17,000. This co-eluted with activity in a preparation of ILl from rat peritoneal macrophage cultures. These results indicate that ILI is responsible for the prostaglandinindependent bone resorbing activity synthesised by these cells in vitro, and may contribute to the bone destruction associated with the tumour.
Bone resorption is a common feature of malignancy and can occur as a consequence of malignant cell growth in or adjacent to bone, or at sites distant from the malignant cells.
The localised bone destruction frequently accompanying squamous cell carcinomas of the head and neck appears to be a two-stage process: the first phase characterised by osteoclastic resorption -presumably stimulated by tumour cell products, and a second phase of resorption by tumour cells themselves (Carter, 1985) .
Since the demonstration of soluble bone resorbing activity produced by mouse fibrosarcoma in vitro (Goldhaber, 1960) , tissue culture has been an important tool for investigating the mechanisms of tumour-induced bone resorption. Prostaglandins (PG), notably PGE2, have been considered prime candidates as local mediators of osteolysis since they are potent stimulators of oesteoclastic bone resorption (Klein & Raisz, 1970) and are synthesised in increased amounts by several tumours in animals, including fibrosarcoma in mice (Tashjian et al., 1972) the VX2 carcinoma in rabbits (Voelkel et al., 1975) , and in man, including carcinoma of the breast (Bennett et al., 1975) ; Dowsett et al., 1976) , and squamous carcinomas of the head and neck (Tsao et al., 1981) . PGs, however, are only one class of bone resorbing factor which may contribute to tumour osteolysis. Tsao et al. (1981 Tsao et al. ( , 1983 showed that the bone resorption induced in culture by explants of squamous cell carcinoma of the head and neck was only partially inhibited by indomethacin. Indeed, carcinoma cell lines cultured from these tumours produced bone resorbing activity in the culture supernatants, but no detectable PGs. This indicated that the PGs synthesised by tumour explants may have originated from other cell types in the tumour, such as stromal fibroblasts.
Another group of arachidonic acid metabolites, the lipoxygenase products, have also been shown to possess bone resorbing activity (Meghji et al., 1987 ). Porteder et al. (1984 demonstrated that tissue from oral squamous cell carcinoma sythesised equal amounts of cyclo-oxygenase prostaglandins and lipoxygenase products.
Several macromolecular bone resorbing factors have been identified recently, including tumour transforming growth factors (TGF) (Ibbotson et al., 1983) , interleukin 1 (ILI) (Gowen et al., 1983) and tumour necrosis factor (TNF) (Bertolini et al., 1986) . It has become clear that ILl and TNF account for much of the bone resorbing activity attributed to 'osteoclast activating factor' (OAF) produced by mononuclear leukocytes (Horton et al., 1972) and myeloma cells (Mundy et al., 1974 resorbing activity of ILl and the fact that it is a normal product of keratinocytes (Luger et al., 1981) , we investigated whether it contributed to the non-prostaglandin bone resorbing activity synthesised by squamous carcinoma cells in vitro.
Materials and Methods

Tumour cells
The three cell lines used were derived from squamous carcinomas of the head and neck associated with localised bone destruction, at the Institute of Cancer Research. The cell lines were established as described by Tsao et al. (1981) . Two of the squamous carcinoma cell lines (HNI1 and 15) were derived from the floor of the mouth and the third (HN12) from the hypopharynx. For preparation of supernatant containing bone resorbing activity the cells were grown to confluence in Eagles minimal essential medium (MEM; Gibco) and 10% foetal calf serum (FCS; Gibco) in 75 cm2 polystyrene culture flasks, supplemented with penicillin, streptomycin and kanomycin (100Uml-1 each), buffered with sodium bicarbonate 2.25gl-1) in a humidified atmosphere of 95% air and 5% CO2. The cells were subcultured weekly with 0.25% trypsin (Gibco). When the cells were confluent the medium was then replaced with serum-free MEM and incubated for a further 3 days. The medium was centrifuged at lOOg to remove any debris and 1 ml aliquots were removed for prostaglandin analysis. 
Mononuclear cell supernatants
Mononuclear cell factor (MCF) was obtained from cultures of adherent rat peritoneal macrophages (106 ml-1) stimulated with concanavalin A (10ngml-1) for 3 days. The culture medium was dialysed against fresh medium and stored at -70°C.
Bone resorption Bone resorption was assayed by the measurement of calcium released from 5-day old mouse calvaria in vitro (Zanelli et al., 1969) . Halved calvaria were cultured singly on stainless steel grids in 30mm dishes (5 per group), with 1.5ml BGJ medium (Flow Laboratories, Scotland), supplemented with 5% complement-inactivated rabbit serum and 50 gml-1 ascorbic acid. After 24 h the media were changed, and dialysed tumour cell medium or MCF was introduced at a dilution of 1:5 to 1:40. MCF (1:10) and PGE2 (10-6M) were used as positive controls. In some of the experiments polyclonal antibody for human ILl (Genzyme, Suffolk, UK) was added to the tumour cell line media and MCF and incubated overnight at 40C before testing for bone resorbing activity. The cultures were incubated for a further 48h and the calcium content of the media was measured by automated colorimetric analysis (Gitelman, 1967) . In order to ascertain the potency of the tumour cell media recombinant human ILl beta was tested on the bone resorbing system in parallel.
Thymocyte proliferation assay Interleukin 1-like activity was measured by its capacity to enhance the mitogen-stimulated proliferation of mouse thymocytes (the 'lymphocyte activation factor' (LAF) assay, Gery et al., 1972) . Briefly, thymocytes from 7-week old C3H-HeJ mice (Harlan Olac, Blackthorn, UK) were plated in 96 well culture plates (Sterilin) at 1.5 x 106 per well in 100 jl RPMI 1640 containing 5% complement-inactivated FCS, 4mM 2-mercaptoethanol, and 0.5pgml-1 concanavalin A.
The cells were cultured for 48h and 3H-thymidine (Amersham International), 0.5pCi per well, was added for the last 6 h. Incorporation of 3H-thymidine into 5% trichloroacetic acid-insoluble material was measured by scintillation counting.
Chondrocyte collagenase assay Rabbit articular chondrocytes were prepared by a method adapted from Evequoz et al. (1984) . Slices of articular cartilage from the knee and shoulder joints of 2-week old New Zealand white rabbits were sequentially digested with 0.5% hylaluronidase (Sigma) for 20min at 37°C, followed by 0.25% trypsin and 0.1% bacterial collagenase (Sigma) for 1 h at 37°C in serum free MEM, then 0.1% bacterial collagenase for 2h in the presence of 10% FCS.
The cells obtained were washed twice and grown to confluence in MEM with 10% FCS. Cell suspensions from the cultures were prepared by trypsin digestion (0.25%), and inoculated into 16mm wells in 24-well culture plates at 200,000 cells per well. The culture medium was removed when the cells were confluent, and 0.5 ml aliquots test preparations diluted in MEM incubated in triplicate wells for 48 h.
The supernatants were assayed for collagenase activity using thermally reconstituted 3H-acetylated rat skin collagen fibrils (Cawston & Barrett, 1979) . Latent collagenase in triplicate 50 jl samples of the supernatants was activated with 20 MI of 10mM 4-amino phenyl mercuric acetate (Sigma) and incubated with collagen fibrils (10,000 dpm/tube) for 5 h at 37°C. Collagenase activity was calculated from the release of radioactivity into the solution, and expressed as U ml where 1 U digests 1 jg of collagen per minute.
Tumour necrosis factor assay The bioassay for TNF activity is based on cytotoxicity to the murine connective tissue cell line L929 (Flick & Gifford, 1984) . Cytotoxicity was measured by the quantitative uptake of methylene blue stain by the cells after fixation (Currie, 1981 ).
L929 cells were seeded into 96-well microtitre plates (Sterilin) at 4 x 104 cells per well. After overnight attachment, the medium was removed and replaced with fresh serum-free MEM containing actinomycin D (1 jg ml-1) and serial dilutions of the standard human recombinant TNF alpha (Genzyme, Suffolk, UK) and tumour cell media at dilution from 1: 1 to 1:256 in MEM. After a 24 h incubation the medium was discarded and the cells were fixed with 5% normal formal-saline and stained with methylene blue. The stain was eluted into 100 Ml 0.1 M HCI, and the absorbance was measured at 650 nm on an automated multi-channel spectrophotometer (Titertek Multiscan, Flow Laboratories, Scotland).
Stimulation offibroblast PGE2 synthesis Fibroblast cultures were established from normal gingival tissue obtained during routine oral surgery, and grown to confluence in MEM with 10% FCS. The medium was changed twice weekly, until primary cultures were established. The fibroblasts were subcultured weekly by trypsinisation (0.25%), and used between the 4th and 8th passage.
Fibroblasts were seeded in 16mm culture wells (Sterilin) at 50,000 cells per well. The test preparations were diluted in MEM and 0.5ml aliquots incubated with the cells for 48h. PGE2 in the culture media was measured by radioimmunoassay: 3H-PGE2 was obtained from Amersham International; PGE2 antiserum from Steranti and PGE2 standards from Sigma.
Results
Bone resorption
The supernatants from all three cell lines caused significant bone resorption, comparable with that produced by MCF. This was partially inhibited by the addition of indomethacin (Figure la) .
The concentration-dependence of resorbing activity in the tumour cell media is shown in Figure lb Thymocyte proliferation The tumour cell culture media enhanced the proliferation of Con A-induced mouse thymocytes, indicating the production of IL-1 like activity (Figure 2 ). The stimulation produced was similar to that obtained by the preparation of MCF.
Chondrocyte collagenase production All three cell lines stimulated collagenase production by rabbit articular chondrocytes in culture (Figure 3) . None of the tumour cell-conditioned media had collagenase activity.
L929 cytotoxicity assay for TNF The concentration of TNF that gave 50% maximal cell killing (1 U) was equivalent to 150 pg ml-1 of recombinant human TNF alpha. There was no detectable TNF activity in any of the tumour cell culture media in any of the concentration tested (results not shown).
Fibroblast PGE2 synthesis All three tumour cell media contained negligible PGE2 (< 0.1 ng ml -1), but enhanced PGE2 synthesis on addition to fibroblasts. The stimulation was comparable to that obtained with the MCF preparation (Figure 4 ).
HPLC
The HPLC fractions were assayed for ILl activity in chondrocyte collagenase assay. The results ( Figure 5 ) showed a single major peak of stimulator activity which co-eluted with that in the MCF preparation at an Mr of 15-17,000. 
Discussion
These results have demonstrated that squamous carcinoma cell lines synthesise an osteolytic factor in vitro with the characteristics of the cytokine ILl. These, and similar cell lines which have previously been validated in terms of their karyotypes, ultrastructure and growth as xenografts, are known to synthesise osteolytic activity which was not attributable to prostaglandin E2, and was largely unaffected - (Tsao et al., 1983) . We have shown that the osteolytic factor is non-dialysable (i.e. has a mol. wt in excess of -10,000) and that the culture medium from the cell lines also contains a non-dialysable factor which has co-mitogenic activity in the thymocyte proliferation (LAF) assay (Figure 2 ), stimulates collagenase synthesis by articular chondrocytes (Figure 3 ) and stimulates PGE 2 synthesis in fibroblast cultures (Figure 4) . The LAF assay and the stimulation of chondrocyte collagenase synthesis are the bioassays normally used to detect ILI. The LAF assay will also detect IL2 (Gery et al., 1972) , but the stimulation of chondrocyte collagenase synthesis is independent of IL2 (Evequoz et al., 1984) , thus indicating ILI activity in the cell culture media.
We have also demonstrated that there is no TNF activity in the supernatants. Studies with the polyclonal antibody for ILI showed that the bone resorbing activity of the supernatant was completely blocked, indicating most of the osteolytic activity in the cell supernatants was ILI-like. Furthermore the stimulation of fibroblast PGE2 synthesis also suggests cytokine activity in the supernatants. This activity in macrophage cultures, first reported by Dayer et al. (1977) , was later shown to be due to ILI (Mizel et al., 1981) . More evidence for the identity of the osteolytic factor as ILI was provided by the inhibitory effect of adding antihuman ILI ( Figure Id) .
Fractionation of the culture media by HPLC (Figure 5 ) showed that the stimulatory activity in the chondrocyte collagenase assay co-eluted with MCF at an Mr of 15-17,000. This is also consistent with its identity as ILI (Dinarello et al., 1977) .
Recently another cytokine, TNF, has also been shown to share several characteristicsof ILI (reviewed by Le & Vilcek, 1987) including the stimulation of bone resorption in vitro (Bertolini et al., 1986) . As the mol. wt of TNF (17,000) is similar to that of ILI it is possible that TNF contributed to the stimulation of bone resorption and PGE2 synthesis by fibroblasts. However, no TNF-like activity was detectable in the tumour cell media over a wide range of dilutions. Furthermore TNF does not exhibit activity in the LAF assay (Dinarello et al., 1985) and does not stimulate metalloproteinase synthesis by chondrocytes (Schnyder et al., 1987) . TNF does not, therefore appear to contribute to the osteolytic activity synthesised by the tumour cell in vitro.
Another family of peptides, tumour-derived transforming growth factors (TGF), have recently been shown to stimulate bone resorption (Tashjian et al., 1985; Ibbotson et al., 1986) and are thought to be potential mediators of tumour-induced osteolysis. However, TGF does not show ILl-like activity in the LAF and chondrocyte collagenase assays, and is therefore unlikely to contribute to the activity which co-elutes with ILl on HPLC.
The initial stages of tumour-induced bone destruction are mediated by osteoclastic activity, whereas the later stages can involve direct invasion and destruction of the bone by tumour cells alone (Galasko & Bennett, 1976; Carter, 1985) . There is much evidence that prostaglandins are synthesised by human carcinomas (Bennett et al., 1975; Dowsett et al., 1976; Tsao et al., 1981 Tsao et al., , 1983 and, in view of their potent bone resorbing activity, notably PGE2 (Klein & Raisz, 1970) , they have been considered prime candidates as osteolytic mediators. The experiments reported by Tsao et al. (1983) showed that although explanted tumour fragments synthesised amounts of PGE2 enough to account for the majority of bone resorption in vitro, the carcinoma cell lines synthesised little prostaglandins but significant prostaglandinindependent osteolytic factors. The experiments reported here show that ILl may account for this PG-independent osteolytic activity.
Although ILl is an extremely potent resorbing peptide and may contribute to osteolysis by the tumour tissue, its ability to stimulate prostaglandin synthesis in connective tissue cells may be of equal or greater importance. Fibroblasts are target cells for ILl action and respond by synthesising prostaglandins -notably PGE2 (Dayer et al., 1977; Mizel et al., 1981) , PGF2 and prostacyclin (Harvey et al., 1984) . In the squamous cell carcinoma, therefore, secretion of ILl by the carcinoma cells is likely to stimulate prostaglandin synthesis by the infiltrating stromal cells such as fibroblasts and capillary endothelial cells.
We propose, therefore that ILl secretion by the carcinoma cells can cause bone resorption by two mechanisms: stimulation of osteoclast activity, probably mediated by osteoblasts (Thomson et al., 1986) , and indirectly by the stimulation of prostaglandin synthesis in stromal cells infiltrating or surrounding the tumour.
